Financial statements Biotech Group
Balance sheet of Biotech Group
Company age:
Age:
9 y. 11 m. 12 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BIOTECH GROUP
|
Year
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Total assets | 315 397,36 | 277 136,03 | 575 329,36 | 880 996,95 |
| A. Fixed assets | 29 750,93 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 285 646,43 | 277 136,03 | 575 329,36 | 880 996,95 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 |
| Total liabilities | 315 397,36 | 277 136,03 | 575 329,36 | 880 996,95 |
| A. Equity | 166 258,75 | 151 751,34 | 327 133,13 | 731 832,77 |
| B. Liabilities and provisions for liabilities | 149 138,61 | 125 384,69 | 248 196,23 | 149 164,18 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | - | 125 384,69 | 225 048,05 | 114 645,66 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.